An integrated multidisciplinary research program is proposed whose aim is to develop general principles of hepatic and intestinal transport of bile acids (BA), bile acid biotransformation during hepatic and intestinal transport as well as principles and mechanisms of bile acid dependent bile flow and biliary lipid secretion. To this end, natural and novel BA will be purchased or synthesized and their physiological properties defined. Biotransformation during hepatic transport and enterohepatic cycling in mammals including man will be quantified using chromatographic and spectroscopic methods. The effect of these bile acids on bile flow and biliary lipid secretion will be measured using biliary fistula animals (including man) as well as the isolated perfused liver. Experiments will be continued to validate (or refute) the presence of cholehepatic cycling as a mechanism of hypercholeresis; the experimental approach will involve pharmocological, physiological, and imaging approaches. In collaborative studies, attempts will be made to identify the canalicular carrier for bile acid glucuronides using photo-affinity labelling techniques and canalicular membrane preparations. Studies will be carried out to test whether active ductular reabsorption of solutes filtered into canalicular bile (such as glucose and amino acids) influences bile flow. Aspects of passive and active intestinal transport of BA in mammals including man will be investigated by a novel intestinal perfusion technique. Attempts will be made to isolate the protein involved in active transport by the terminal ileum. Multicompartmental modelling of the metabolism and enterohepatic circulation of BA in man will be continued in collaborative studies. Biliary bile acid and phospholipid composition in a spectrum of vertebrates will be defined to develop principles of BA evolution An attempt will be made to develop a cell culture technique for studying biliary secretion since available techniques are unsatisfactory. If successful, experiments proposed in this application should give rise to new methods for studying biliary secretion and should permit biliary bile flow and biliary lipid secretion to be described by general principles; elucidation of these principles should lead to new prophylactic and therapeutic approaches to cholelithiasis and cholestasis, and possibly to liver cell injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK021506-14
Application #
3227014
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1978-04-01
Project End
1993-03-31
Budget Start
1991-04-01
Budget End
1992-03-31
Support Year
14
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Hofmann, Alan F; Zakko, Salam F; Lira, Marco et al. (2005) Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology 42:1391-8
Jover, A; Meijide, F; Soto, Victor H et al. (2004) Successful prediction of the hydrogen bond network of the 3-oxo-12alpha-hydroxy-5beta-cholan-24-oic acid crystal from resolution of the crystal structure of deoxycholic acid and its three 3,12-dihydroxy epimers. Steroids 69:379-88
Meng, Ling-Jie; Wang, Pijun; Wolkoff, Allan W et al. (2002) Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2. Hepatology 35:1031-40
Cantz, T; Nies, A T; Brom, M et al. (2000) MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells. Am J Physiol Gastrointest Liver Physiol 278:G522-31
Hofmann, A F (1999) The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159:2647-58
Gruy-Kapral, C; Little, K H; Fordtran, J S et al. (1999) Conjugated bile acid replacement therapy for short-bowel syndrome. Gastroenterology 116:15-21
Bolder, U; Trang, N V; Hagey, L R et al. (1999) Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats. Gastroenterology 117:962-71
Ricci, P; Hofmann, A F; Hagey, L R et al. (1998) Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. Dig Dis Sci 43:1292-5
Hagey, L R; Schteingart, C D; Rossi, S S et al. (1998) An N-acyl glycyltaurine conjugate of deoxycholic acid in the biliary bile acids of the rabbit. J Lipid Res 39:2119-24
Venkataramani, A; Strong, R M; Anderson, D S et al. (1998) Abnormal duodenal bile composition in patients with acalculous chronic cholecystitis. Am J Gastroenterol 93:434-41

Showing the most recent 10 out of 95 publications